Detalhe da pesquisa
1.
Safety and Efficacy of Encorafenib, Binimetinib, and Cetuximab for BRAFV600E-Mutant Metastatic Colorectal Cancer: Results of the Japanese Expanded Access Program.
Clin Colorectal Cancer
; 23(2): 174-182.e6, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38553360
2.
Combinational risk factors of metabolic syndrome identified by fuzzy neural network analysis of health-check data.
BMC Med Inform Decis Mak
; 12: 80, 2012 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-22853735
3.
Phase I studies of peptide vaccine cocktails derived from GPC3, WDRPUH and NEIL3 for advanced hepatocellular carcinoma.
Immunotherapy
; 13(5): 371-385, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33525928
4.
Identification of an interaction between VWF rs7965413 and platelet count as a novel risk marker for metabolic syndrome: an extensive search of candidate polymorphisms in a case-control study.
PLoS One
; 10(2): e0117591, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-25646961